Table 1.
Selected demographic, exposure, and health outcome measures from the fourth evaluation in 712 current and former lead workersa
Characteristic | All Participants |
---|---|
N (%) | |
Female | 149 (20.9) |
Diabetes | 27 (3.8) |
Hypertension | 86 (12.1) |
Former lead workers | 234 (32.9) |
Smoking | |
Never | 242 (34.0) |
Current | 310 (43.5) |
Former | 160 (22.5) |
Alcohol use | |
Never | 109 (15.3) |
Current | 571 (80.2) |
Former | 32 (4.5) |
Education | |
Less than middle school graduate | 180 (25.3) |
Less than high school graduate | 182 (25.6) |
High school graduate | 294 (41.3) |
Median | Mean (SD) | Range | |
---|---|---|---|
Age, years | 46.7 | 47.6 (7.9) | 24.1–71.3 |
BMI, kg/m2 | 24.2 | 24.2 (2.8) | 15.6–33.3 |
Systolic blood pressure, mm Hg | 121.5 | 123.7 (15.5) | 90.5–213.3 |
Diastolic blood pressure, mm Hg | 74.3 | 75.2 (12.0) | 46.0–147.0 |
Urine cadmium, μg/g creatininea | 0.84 | 1.02 (0.65) | 0.17–4.63 |
Urine cadmium, μg/Lb | 0.65 | 0.89 (0.73) | 0.06–5.4 |
Urine creatinine, mg/dL | 82.2 | 94.4 (58.1) | 11.8–342.7 |
Blood lead, μg/dL | 21.4 | 23.1 (14.1) | 1.9–74.4 |
Tibia lead, μg Pb/g bone mineral | 19 | 26.6 (28.9) | −12–231 |
Lead job duration, years | 13.2 | 13.1 (7.3) | 0.23–37.4 |
Serum creatinine, mg/dl | 0.87 | 0.87 (0.15) | 0.42–1.53 |
Serum cystatin C, mg/L | 0.72 | 0.73 (0.12) | 0.50–2.35 |
Single var. cystatin C eGFR, mL/min/1.73 m2 | 113.9 | 113.7 (16.7) | 27.8–176.3 |
Multi-var. cystatin C eGFR, mL/min/1.73 m2 | 112.8 | 112.0 (17.7) | 28.1–186.3 |
Dual biomarker eGFR, mL/min/1.73 m2 | 105.8 | 106.1 (17.5) | 24.3–174.5 |
MDRD eGFR, mL/min/1.73 m2 | 95.5 | 97.4 (19.2) | 23.6–189.7 |
modified from Weaver et al., 2011
molybdenum-corrected